Related Experiment Video
Updated: Aug 4, 2026

07:45
An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
Published on: October 21, 2014
Primary progressive aphasia with glial cytoplasmic inclusions
J A Molina1, A Probst, C Villanueva
1Department of Neurology of University Hospital 'Doce de Octubre', Madrid, Spain.
European Neurology
|August 7, 1998
Summary
This study details a rare case of primary progressive aphasia (PPA) with unique glial tau pathology. The findings suggest a distinct subtype of PPA with implications for understanding neurodegenerative diseases.
Area of Science:
- Neuropathology
- Neurodegenerative Diseases
- Neuroimaging
Background:
- Primary progressive aphasia (PPA) is a neurodegenerative syndrome characterized by gradual language decline.
- Typical neuropathological findings in PPA include tauopathies or TDP-43 proteinopathies affecting cortical neurons.
- The current case presents atypical neuropathological features distinct from previously described PPA subtypes.
Observation:
- An 80-year-old woman with a 3-year history of PPA showed cerebral atrophy and hypometabolism in left frontal and temporal lobes on CT, MRI, and SPECT.
- Temporal lobe biopsy revealed Gallyas-positive intracytoplasmic inclusions in glial cells, resembling those in multiple system atrophy.
- These inclusions contained hyperphosphorylated tau (p-tau) and ubiquitin, with minimal neuronal tau pathology and absence of other common neurodegenerative markers.
Findings:
- The neuropathological examination identified glial intracytoplasmic inclusions with hyperphosphorylated tau.
- These inclusions differed significantly from the neuronal pathology typically observed in primary progressive aphasia.
- The observed glial pathology shared similarities with inclusions found in multiple system atrophy.
Implications:
- This case suggests a potential novel subtype of primary progressive aphasia characterized by glial tau inclusions.
- The findings expand the spectrum of tauopathies and their clinical manifestations in neurodegenerative disorders.
- Further research is needed to elucidate the pathogenesis and clinical significance of this glial tau pathology in PPA.
More Related Videos
Related Concept Videos
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

